• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定显著影响肝细胞癌免疫微环境和免疫治疗反应的代谢术语。

Identification of metabolism terms significantly affecting hepatocellular carcinoma immune microenvironment and immunotherapy response.

机构信息

Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.

出版信息

J Cell Mol Med. 2024 Jan;28(1):e18018. doi: 10.1111/jcmm.18018. Epub 2023 Nov 9.

DOI:10.1111/jcmm.18018
PMID:37944063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10805494/
Abstract

Metabolic pathways exert a significant influence on the onset and progression of cancer. Public data on hepatocellular carcinoma (HCC) patients were obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Analysis was performed in R software using different R packages. Here, we integrated the data from multiple independent HCC cohorts, including TCGA-LIHC, ICGC-FR and ICGC-JP. Then, the enrichment score of 21 metabolism-related pathways was quantified using the ssGSEA algorithm. Next, univariate Cox regression analysis was applied to identify the metabolic terms with significant correlation to patient survival. Finally, a prognosis model based on linoleic acid metabolism, sphingolipid metabolism and regulation of lipolysis in adipocytes was established, which showed good performance in predicting patients' survival. Furthermore, we conducted a biological enrichment analysis to delineate the biological disparities between high- and low-risk patients. Notably, we discerned differences in the microenvironments between these two patient groups. We also found that low-risk patients could potentially respond better to immunotherapy. Drug sensitivity analysis suggested that low-risk patients are more susceptible to bexarotene and erlotinib, yet exhibit resistance to ATRA and bleomycin. Furthermore, through the use of LASSO logistic regression analysis, we identified 19 characteristic genes, which could robustly indicate the risk groups. Our research underscores the role of linoleic acid metabolism, sphingolipid metabolism and the regulation of lipolysis in adipocytes in HCC, pointing towards potential avenues for future research.

摘要

代谢途径对癌症的发生和发展有重要影响。我们从癌症基因组图谱(TCGA)和国际癌症基因组联合会(ICGC)数据库中获得了肝细胞癌(HCC)患者的公共数据。在 R 软件中使用不同的 R 包进行了分析。在这里,我们整合了来自多个独立 HCC 队列的数据,包括 TCGA-LIHC、ICGC-FR 和 ICGC-JP。然后,使用 ssGSEA 算法量化了 21 条代谢相关途径的富集评分。接下来,应用单变量 Cox 回归分析来识别与患者生存显著相关的代谢术语。最后,建立了一个基于亚油酸代谢、鞘脂代谢和脂肪细胞脂肪分解调节的预后模型,该模型在预测患者生存方面表现良好。此外,我们进行了生物学富集分析,以描绘高风险和低风险患者之间的生物学差异。值得注意的是,我们发现这两组患者的微环境存在差异。我们还发现低风险患者可能对免疫治疗有更好的反应。药物敏感性分析表明,低风险患者更容易对倍他罗汀和厄洛替尼敏感,但对 ATRA 和博来霉素有抗性。此外,通过使用 LASSO 逻辑回归分析,我们确定了 19 个特征基因,这些基因可以可靠地指示风险组。我们的研究强调了亚油酸代谢、鞘脂代谢和脂肪细胞脂肪分解调节在 HCC 中的作用,为未来的研究指明了方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/885ad6df9cd1/JCMM-28-e18018-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/737188b2f9ed/JCMM-28-e18018-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/3fac8cf734b4/JCMM-28-e18018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/b7c483139b06/JCMM-28-e18018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/95d655678d12/JCMM-28-e18018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/0b174c86321a/JCMM-28-e18018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/4ee3e7a836b9/JCMM-28-e18018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/5c8b55c52dec/JCMM-28-e18018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/885ad6df9cd1/JCMM-28-e18018-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/737188b2f9ed/JCMM-28-e18018-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/3fac8cf734b4/JCMM-28-e18018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/b7c483139b06/JCMM-28-e18018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/95d655678d12/JCMM-28-e18018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/0b174c86321a/JCMM-28-e18018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/4ee3e7a836b9/JCMM-28-e18018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/5c8b55c52dec/JCMM-28-e18018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d2/10805494/885ad6df9cd1/JCMM-28-e18018-g008.jpg

相似文献

1
Identification of metabolism terms significantly affecting hepatocellular carcinoma immune microenvironment and immunotherapy response.鉴定显著影响肝细胞癌免疫微环境和免疫治疗反应的代谢术语。
J Cell Mol Med. 2024 Jan;28(1):e18018. doi: 10.1111/jcmm.18018. Epub 2023 Nov 9.
2
Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma.鉴定五个免疫标志物用于预测和治疗选择(免疫治疗与靶向治疗)对肝癌患者。
Comput Math Methods Med. 2023 Feb 2;2023:8958962. doi: 10.1155/2023/8958962. eCollection 2023.
3
Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.鉴定调控肝癌肿瘤免疫微环境和预后的 COVID-19 关键基因。
Funct Integr Genomics. 2023 Aug 4;23(3):262. doi: 10.1007/s10142-023-01184-z.
4
Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.超重/肥胖相关的转录组特征与肝细胞癌的临床结局、免疫微环境和治疗反应相关。
Front Endocrinol (Lausanne). 2023 Jan 12;13:1061091. doi: 10.3389/fendo.2022.1061091. eCollection 2022.
5
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.铜死亡相关长链非编码 RNA 风险模型预测肝细胞癌患者的预后和免疫治疗疗效。
Biochem Genet. 2024 Jun;62(3):2332-2351. doi: 10.1007/s10528-023-10539-x. Epub 2023 Oct 29.
6
Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.缺氧和 m6A/m5C/m1A 调控基因特征的联合探索和验证用于肝癌预后预测。
BMC Genomics. 2023 Dec 14;24(1):776. doi: 10.1186/s12864-023-09876-3.
7
A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.一个与坏死性凋亡相关的基因特征,可用于预测肝细胞癌的预后、免疫图谱和药物敏感性。
Cancer Med. 2022 Dec;11(24):5079-5096. doi: 10.1002/cam4.4812. Epub 2022 May 13.
8
Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.鞘脂标志物的预后特征:了解免疫图谱及其在预测肝癌免疫治疗反应和结局中的作用。
Front Immunol. 2023 Mar 17;14:1153423. doi: 10.3389/fimmu.2023.1153423. eCollection 2023.
9
A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.一种包含脂质代谢和免疫相关基因的新型特征,用于预测肝细胞癌的预后和免疫格局。
Front Oncol. 2023 Jun 6;13:1182434. doi: 10.3389/fonc.2023.1182434. eCollection 2023.
10
Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.肝癌免疫抑制微环境中的低氧特征。
Front Immunol. 2021 Feb 17;12:611058. doi: 10.3389/fimmu.2021.611058. eCollection 2021.

本文引用的文献

1
Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling.突变型 Kras 和 mTOR 相互作用通过 PEG3/STAT3/BEX2 信号通路驱动肝细胞癌的发展。
Theranostics. 2022 Nov 16;12(18):7903-7919. doi: 10.7150/thno.76873. eCollection 2022.
2
Evolving therapeutic landscape of advanced hepatocellular carcinoma.晚期肝细胞癌不断演变的治疗格局。
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11.
3
GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth.
GOLM1 缺失会改变细胞鞘脂代谢,并对细胞生长产生不利影响。
J Lipid Res. 2022 Sep;63(9):100259. doi: 10.1016/j.jlr.2022.100259. Epub 2022 Aug 7.
4
Linoleic Acid Upregulates Microrna-494 to Induce Quiescence in Colorectal Cancer.亚油酸通过上调 microRNA-494 诱导结直肠癌细胞静止
Int J Mol Sci. 2021 Dec 25;23(1):225. doi: 10.3390/ijms23010225.
5
Cell cycle checkpoint control in response to DNA damage by environmental stresses.环境应激引起的 DNA 损伤的细胞周期检验点控制。
Plant J. 2022 Feb;109(3):490-507. doi: 10.1111/tpj.15567. Epub 2021 Nov 22.
6
Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis.调节性 T 细胞与中性粒细胞胞外诱捕网相互作用促进非酒精性脂肪性肝炎的发生发展。
J Hepatol. 2021 Dec;75(6):1271-1283. doi: 10.1016/j.jhep.2021.07.032. Epub 2021 Aug 4.
7
Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma.整合代谢组学特征分析鉴定出改变的门静脉血清代谢组,有助于人类肝细胞癌的发生。
Gut. 2022 Jun;71(6):1203-1213. doi: 10.1136/gutjnl-2021-325189. Epub 2021 Aug 3.
8
Epigenetics in hepatocellular carcinoma.肝细胞癌中的表观遗传学。
Semin Cancer Biol. 2022 Nov;86(Pt 3):622-632. doi: 10.1016/j.semcancer.2021.07.017. Epub 2021 Jul 26.
9
HCC advances in diagnosis and prognosis: Digital and Imaging.肝癌的诊断和预后进展:数字和成像技术。
Liver Int. 2021 Jun;41 Suppl 1:73-77. doi: 10.1111/liv.14865.
10
ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.ZEB1 通过转录激活 PFKM 增强了肝癌的瓦博格效应,促进了肿瘤的发生和转移。
Theranostics. 2021 Apr 3;11(12):5926-5938. doi: 10.7150/thno.56490. eCollection 2021.